Enhance surgical visualization and reduce procedure interruptions with real-time AI-powered image enhancement for minimally invasive endoscopic surgeries.
QAS.AI
Improve surgical precision and outcomes during neuro-vascular procedures with real-time AI-based decision support for aneurysm detection and occlusion.
About QAS.AI
QAS.AI is an advanced artificial intelligence platform designed specifically for the procedure room, providing real-time decision support for neuro-vascular surgery. By analyzing angiographic imaging as it happens, the tool assists medical professionals in managing complex cerebrovascular diseases. Its primary purpose is to enhance the safety and precision of neuroendovascular procedures, offering immediate insights that help interventionalists make more informed decisions during critical moments of surgery. The tool operates with impressive speed, moving from angiography to actionable data in less than one second. It features specialized algorithms to detect aneurysms instantly and estimate the likelihood of occlusion with high confidence. One of its standout functional aspects is its ability to integrate directly into existing angiographic imaging workflows. This ensures that feedback is provided without disrupting the natural flow of the procedure, extending case times, or requiring surgeons to take additional manual steps to access the AI's findings. QAS.AI is primarily built for neurointerventionalists, interventional radiologists, and surgical teams working within the procedure room. It is particularly valuable for clinicians treating patients with complex cerebrovascular conditions where real-time adjustments to device choice or strategy are necessary. Beyond its current focus, the platform is expanding to address other flow-driven conditions such as intracranial atherosclerosis, arteriovenous malformations (AVMs), and ischemic stroke, making it a versatile tool for comprehensive vascular care. What distinguishes QAS.AI from traditional post-processing software is its real-time mid-procedure feedback and its high accuracy rate. Boasting a 90%+ accuracy in lesion localization and inlet detection, it significantly reduces the uncertainty often caused by imaging variability. Furthermore, the company is actively engaged in multi-center clinical studies and partnerships with major imaging vendors, ensuring the technology is validated by rigorous clinical standards while remaining accessible within diverse surgical ecosystems.
QAS.AI pros & cons
Pros
- Delivers AI-based insights in under one second for immediate surgical use.
- Achieves over 90% accuracy in lesion localization and inlet detection.
- Integrates directly into existing angiographic workflows without disrupting surgical flow.
- Supports mid-procedure adjustments to device choice and positioning based on real-time data.
Cons
- Currently undergoing multi-center clinical studies for full validation of some indications.
- Pricing and specific integration requirements are not publicly listed and require a demo.
QAS.AI use cases
- Neurointerventionalists can use real-time occlusion probability data to adjust device choices or reposition strategies mid-procedure for better patient outcomes.
- Surgical teams in the procedure room can automate aneurysm detection during angiography to reduce diagnostic uncertainty caused by imaging variability.
- Clinical researchers can participate in multi-center studies to help validate AI-driven predictive standards for flow-driven vascular conditions.
QAS.AI features
- occlusion likelihood estimation
- instant aneurysm detection
- real-time ai decision support
- multi-center clinical validation
- flow-driven condition analysis
- mid-procedure strategy adjustment
- 90%+ lesion localization accuracy
- angiographic imaging integration
QAS.AI FAQs
How fast does QAS.AI provide results during a procedure?
The platform is designed for real-time operation, delivering results from angiography to actionable insights in under one second. This speed allows interventionalists to make immediate decisions without pausing the surgical flow.
What is the accuracy rate of the lesion localization?
QAS.AI offers a high level of precision with over 90% accuracy in lesion localization and inlet detection. This reliability helps clinicians eliminate misdiagnoses that can occur due to imaging variability during complex cases.
Does the software require additional hardware or steps in the procedure room?
No, the tool is designed for seamless workflow integration and connects directly into existing angiographic imaging systems. It provides feedback without requiring additional steps or extending the overall time of the case.
Which conditions can QAS.AI help treat?
Currently, the tool focuses on assisting with complex cerebrovascular diseases and aneurysm detection. However, the platform is being expanded to support other flow-driven conditions like intracranial atherosclerosis, AVMs, and ischemic stroke.
Is QAS.AI clinically validated?
Multi-center clinical studies are currently underway to validate the platform as a predictive and diagnostic standard. These studies are essential for accelerating regulatory pathways and ensuring clinical adoption in various healthcare settings.
Ratings & reviews
No reviews yet. Be the first to share how QAS.AI worked for you.
Alternatives to QAS.AI
Deliver consistent clinical excellence with real-time AI guidance, automated documentation, and sterile processing verification for surgical teams and hospitals.
Sponsored tools
Test your knowledge in live multiplayer Jeopardy-style trivia battles with AI-assisted grading that recognizes correct answers even with spelling mistakes.
Connect with engaged niche audiences or monetize your subscriber base through an automated marketplace featuring verified metrics and secure Stripe payments.
Create full vocal songs, instrumental tracks, and stem splits in seconds using intuitive text prompts, custom lyrics, and advanced AI music models.
Swap characters, backgrounds, or styles in any video while preserving original motion and camera paths. Perfect for digital marketers and creators.